GNOM

Fund Description
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology.
Fund Profile
Fund Name Genomics & Biotechnology ETF
Fund Exchange Ticker GNOM
Fund Sponsor Global X
Fund ISIN US37954Y4347
Net Expense Ratio 0.50 %
Fund Inception Date 5 April 2019
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Solactive Genomics Index
Index Provider Solactive AG
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 22 January 2021
Asset Under Management 0.00 Million (USD)
1 Month Total Return 4.75 %
Year To Date Return 11.39 %
1 Year Total Return 70.52 %
3 Year Annualized Total Return
NAV
Share Outstanding
Top 10 Holdings (21 January 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
PACIFIC BIOSCIENCES OF CALIF PACB EQUI 0.0570200000
CRISPR THERAPEUTICS AG CRSP EQUI 0.0561800000
NATERA INC NTRA EQUI 0.0517400000
ULTRAGENYX PHARMACEUTICAL IN RARE EQUI 0.0402600000
CAREDX INC CDNA EQUI 0.0401500000
ARROWHEAD PHARMACEUTICALS IN ARWR EQUI 0.0386900000
ALNYLAM PHARMACEUTICALS INC ALNY EQUI 0.0383300000
EDITAS MEDICINE INC EDIT EQUI 0.0378800000
ILLUMINA INC ILMN EQUI 0.0375300000
AGILENT TECHNOLOGIES INC A EQUI 0.0358800000